Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06813430 · ClinicalTrials.gov registry record · NA
Non-Contact Low-Frequency Ultrasound Vs Standard LaLonde Protocol for Fingertip Injury Wound Healing
A NA study of Non-contact Low Frequency Ultrasound and Lalonde Protocol, sponsored by St. Luke's Hospital, Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT06813430: Recruiting NA study of Non-contact Low Frequency Ultrasound and Lalonde Protocol, sponsored by St. Luke's Hospital, Pennsylvania.
NCT06813430 is a NA study of Non-contact Low Frequency Ultrasound and Lalonde Protocol that is actively recruiting participants, run by St. Luke's Hospital, Pennsylvania. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06813430, a NA study of Non-contact Low Frequency Ultrasound and Lalonde Protocol, is actively recruiting participants, sponsored by St. Luke's Hospital, Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the efficacy of non-contact low frequency ultrasound in populations sustaining fingertip amputations. The main question it aims to answer is: • Does non-contact low frequency ultrasound significantly improve patient outcomes in patients sustaining acute fingertip amputations? Researchers will compare non-contact low frequency ultrasound to a standard Lalonde protocol to answer this questions. Participants will be randomized one of the two study arms and evaluated by wound care therapy. They will receive cohort appropriate therapy sessions 2-3 times per week with measurement of wound size once per week.
Primary Outcome
Would dimensions will be measured in two dimensions using a ruler and recorded.
Conditions Studied
Interventions
- DEVICE Non-contact Low Frequency Ultrasound
- OTHER Lalonde Protocol (standard of care)
Study Locations (1)
Pennsylvania
- St. Luke's University Health Network - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2025-02-10 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT06813430 shows while recruiting
NCT06813430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Non-contact Low Frequency Ultrasound appearing as the primary indexed condition, and to 2 interventions - of which Non-contact Low Frequency Ultrasound is the first listed.
NCT06813430 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06813430 about?
NCT06813430 is a clinical study titled "Non-Contact Low-Frequency Ultrasound Vs Standard LaLonde Protocol for Fingertip Injury Wound Healing". The goal of this clinical trial is to compare the efficacy of non-contact low frequency ultrasound in populations sustaining fingertip amputations. The main question it aims to answer is: • Does non-contact low frequency ultrasound significantly improve patient outcomes in patients sustaining acute...
What is the current status of trial NCT06813430?
This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2025-02-10. Estimated completion is 2026-02.
What conditions does trial NCT06813430 study?
This clinical trial studies the following conditions: Non-contact Low Frequency Ultrasound, Lalonde Protocol, Fingertip Amputation.
What interventions are being tested in trial NCT06813430?
The interventions under investigation include: Non-contact Low Frequency Ultrasound (DEVICE), Lalonde Protocol (standard of care) (OTHER).
Who is sponsoring clinical trial NCT06813430?
This trial is sponsored by St. Luke's Hospital, Pennsylvania, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06813430 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06813430's enrollment target sits among peer trials
22 1757th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI